Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F4GA1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,260
Award facts
- Contract value 100% obligated
- $12,259.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 6, 2026, for the supply of XELJANZ XR 11 mg tablets in 30-count units, with a contract value of $12,259.73 and completion deadline of January 7, 2026. This is a firm fixed-price delivery order issued under a non-competitive, non-set-aside procurement, and the place of performance is located at the company's corporate office in Conshohocken, Pennsylvania. XELJANZ XR is a branded pharmaceutical treatment for rheumatoid arthritis and other autoimmune conditions, representing routine pharmaceutical supply fulfillment for military healthcare needs.
This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at up to $999,999,999.00 and running through December 2026. This prime contract vehicle enables comprehensive global pharmaceutical support to military healthcare programs, covering a broad spectrum of specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The DLA Troop Support Medical contracts with Amerisourcebergen and other prime vendors to ensure reliable pharmaceutical supply chains supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26F4GA1?
SPE2DR26F4GA1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F4GA1 worth?
The government has obligated $12,260 on SPE2DR26F4GA1.
Is contract SPE2DR26F4GA1 an order under another contract?
Yes. SPE2DR26F4GA1 is a delivery order under SPE2DR25D3015, an indefinite delivery contract.
Was contract SPE2DR26F4GA1 competed?
The extent of competition for SPE2DR26F4GA1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award